当前位置: X-MOL 学术Neurol. Genet. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Differential subcellular expression of P525LFUS as a putative biomarker for ALS phenoconversion
Neurology Genetics ( IF 3.1 ) Pub Date : 2020-04-01 , DOI: 10.1212/nxg.0000000000000410
Maria Caputo 1 , Vincenzo La Bella 1 , Antonietta Notaro 1
Affiliation  

P525LFused-in-Sarcoma (FUS) mutation is associated with a specific amyotrophic lateral sclerosis (ALS) phenotype characterized by a juvenile-onset and a severe course.1 This harmful point mutation is located in the nuclear localization signal (NLS) domain at the protein C-terminal.2 Although wild-type FUS protein is expressed almost exclusively in the nucleus, the P525LFUS mutation leads to a protein mislocalization into the cytoplasm3,4 because of its loss of capacity to bind its transporter karyopherin-2 and to be transferred back to the nucleus.3



中文翻译:

P525LFUS的亚细胞表达差异作为ALS表型转化的可能生物标记

P525L融合型肉瘤(FUS)突变与特定的肌萎缩性侧索硬化症(ALS)表型有关,该表型的特征是少年发作和严重病程。1此有害点突变位于蛋白C端的核定位信号(NLS)域中。2尽管野生型FUS蛋白几乎只在细胞核中表达,但P525L FUS突变会导致蛋白质定位到细胞质中3,4,因为它失去了结合转运蛋白karyopherin-2并转移回细胞核的能力。核。3

更新日期:2020-04-01
down
wechat
bug